In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hi-Tech Pharmacal Co. Inc.

http://www.hitechpharm.com/

Latest From Hi-Tech Pharmacal Co. Inc.

MSD Removes ‘Key Barrier’ To English Funding For Keytruda In Triple-Negative Breast Cancer

MSD has agreed to restrict the use of its Keytruda combination therapy in a manner that means that Roche’s Tecentriq combination is no longer a direct comparator.

Cost Effectiveness Reimbursement

Ukraine War Could Spur Changes In The Clinical Trial Paradigm

Decentralized trials are way to help displaced Ukrainians remain in studies and could encourage greater participation from individuals in other countries, those overseeing sites in Ukraine say.

Clinical Trials Policy

Homegrown China Oral Antiviral Shows Early Promise

Junshi’s oral antiviral shows signs of effectiveness in treating patients with mild COVID-19 symptoms but more data are needed, caution researchers.

China Coronavirus COVID-19

Scotland Okays Funding For Keytruda and Opdivo For Esophageal Cancer, Among Other Drugs

Immunotherapies for esophageal cancer from BMS and MSD are among the medicines that Scotland’s health technology appraisal body has recommended for use on the National Health system.

United Kingdom Health Technology Assessment
See All

Company Information

  • Other Names / Subsidiaries
    • ECR Pharmaceuticals
UsernamePublicRestriction

Register